Preferred Label : hallucinogens;

MeSH definition : Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.;

MeSH synonym : agents, psychotomimetic; drugs, hallucinogenic; psychedelic agents; psychotomimetic agents; hallucinogenic agents; agents, hallucinogenic; hallucinogenic substances; substances, hallucinogenic; agents, psychedelic; hallucinogenic drugs; psychedelics; Hallucinogenic Agent; Agent, Hallucinogenic; Psychedelic; Psychotomimetic Agent; Agent, Psychotomimetic; Hallucinogenic Drug; Drug, Hallucinogenic; Hallucinogenic Substance; Substance, Hallucinogenic; Psychedelic Agent; Agent, Psychedelic; Hallucinogen;

MeSH annotation : GEN or unspecified; prefer specifics; consider also HALLUCINATIONS /chem ind;

Wikipedia link : https://en.wikipedia.org/wiki/Hallucinogen;

Is substance : O;

action pharmacologique : O;

Details


Main resources

You can consult :

Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.

https://www.psychiatrie.ch/fileadmin/SGPP/user_upload/Fachleute/Empfehlungen/SSPP_Reccommandations_therapeutiques_troubles_psychedeliques_18.9.24.pdf
2024
Switzerland
practice guideline
psyche, nos
therapeutics
mental disorders
hallucinogens
health planning guidelines

---
https://www.cochrane.org/fr/CD015383/CENTRALED_therapie-assistee-par-psychedeliques-pour-le-traitement-de-lanxiete-de-la-depression-et-de-la
2024
United Kingdom
review of literature
french abstract
counseling
therapy, nos
disease
persons
depressive disorder
depression
disease, nos
distress, nos
anxious mood
anxiety
hallucinogens
anxiety
depression, nos

---
https://dumas.ccsd.cnrs.fr/dumas-04200445
2023
France
dissertations, academic
Drug Tolerance
Meta-Analysis
alcohols
Ethanol Measurement
Ethanol
Data Driven Analysis
Treatment
Therapeutic Procedure
Scientific Equipment
Retrospective Study
Substance
Attributable, Legible, Contemporaneous, Original, Accurate
Immunologic Tolerance
retrospective studies
Alcohol
Disease or Disorder
tool, nos
meta-analysis as topic
Tolerance
Meta-Analysis
Attributable, Legible, Contemporaneous, Original, Accurate Plus
alcohol, nos
alcoholics
Therapeutic
hallucinogens
alcoholism
therapeutics
tolerance, nos
Tool
Data Analysis
Tolerability Study
ethyl alcohol
Usage

---
https://www.medg.fr/addiction-aux-substances-hallucinogenes
2018
France
teaching material
scientific and technical information
behavior, addictive
dependent drug abuse
hallucinogenic drug, nos
Addiction
hallucinogens
substance-related disorders

---
https://saez.swisshealthweb.ch/fr/article/doi/sanp.2017.00487/
2017
false
false
false
Switzerland
French
journal article
hallucinogens
medicine

---
http://www-sante.univ-rouen.fr/biolog2/Pages/Myco%20et%20Pharma/sd%20psilocybien.htm
2014
false
false
false
France
educational course
syndrome
hallucinogens

---
http://dumas.ccsd.cnrs.fr/dumas-00780547
2013
dissertations, academic
plant structures
hallucinogens
western world
orientation

---
https://www.ofdt.fr/publication/2013/drogues-et-addictions-donnees-essentielles-edition-2013-1001
2013
false
France
French
drug users
behavior, addictive
drug and narcotic control
alcohol-related disorders
tobacco use disorder
substance-related disorders
alcohol drinking
gambling
Illicit Drugs
crack cocaine
hallucinogens
cocaine-related disorders
opioid-related disorders
amphetamine-related disorders
psychotropic drugs
amphetamines
adhesives
solvents
technical report
cocaine
cannabis
marijuana smoking
marijuana abuse

---
https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=54211
2006
false
false
false
reports and studies
data collection
plants
france
hallucinogens
fungi
plant structures
culture

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/064000007.pdf
2005
false
France
French
cocaine
cocaine
cocaine
N-Methyl-3,4-methylenedioxyamphetamine
N-Methyl-3,4-methylenedioxyamphetamine
N-Methyl-3,4-methylenedioxyamphetamine
amphetamines
amphetamines
amphetamines
hallucinogens
mushroom poisoning
ketamine
ketamine
ketamine
lysergic acid diethylamide
lysergic acid diethylamide
lysergic acid diethylamide
cannabis
cannabis
cannabis
marijuana abuse
marijuana abuse
psychotropic drugs
flunitrazepam
flunitrazepam
flunitrazepam
trihexyphenidyl
trihexyphenidyl
trihexyphenidyl
crack cocaine
crack cocaine
crack cocaine
clonazepam
clonazepam
clonazepam
diazepam
diazepam
diazepam
substance-related disorders
substance-related disorders
substance-related disorders
substance-related disorders
opioid-related disorders
opioid-related disorders
amphetamine-related disorders
amphetamine-related disorders
cocaine-related disorders
cocaine-related disorders
france
age distribution
sex distribution
health surveys
socioeconomic factors
adolescent
adult
urban population
population characteristics
heroin
heroin
heroin
buprenorphine
buprenorphine
buprenorphine
methadone
methadone
methadone
morphine
morphine
morphine
codeine
codeine
codeine
technical report
dictionaries, medical
table
public health evaluation

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/034000486.pdf
2003
false
France
French
france
substance-related disorders
age distribution
substance-related disorders
central nervous system stimulants
narcotics
hallucinogens
psychotropic drugs
health surveys
data collection
population characteristics
sex distribution
opioid-related disorders
injections
hiv infections
substance-related disorders
acquired immunodeficiency syndrome
hepatitis C
hepatitis B
injections
opioid-related disorders
heroin
opioid-related disorders
buprenorphine
buprenorphine
heroin dependence
amphetamine-related disorders
buprenorphine
buprenorphine
heroin
methadone
methadone
morphine
morphine
codeine
codeine
N-Methyl-3,4-methylenedioxyamphetamine
amphetamine
amphetamine-related disorders
cocaine-related disorders
crack cocaine
cocaine
cocaine-related disorders
cocaine
N-Methyl-3,4-methylenedioxyamphetamine
socioeconomic factors
hallucinogens
N-Methyl-3,4-methylenedioxyamphetamine
N-Methyl-3,4-methylenedioxyamphetamine
hallucinogens
hallucinogens
methamphetamine
methamphetamine
amphetamine
methamphetamine
amphetamine
central nervous system stimulants
central nervous system stimulants
lysergic acid diethylamide
lysergic acid diethylamide
lysergic acid diethylamide
ketamine
urban population
ketamine
ketamine
adult
flunitrazepam
psychotropic drugs
paris
trihexyphenidyl
Sex Work
alcoholism
marijuana smoking
substance-related disorders
sex workers
technical report

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/024000138.pdf
2002
France
French
adolescent
behavior, addictive
interpersonal relations
pregnancy
child
risk-taking
substance-related disorders
signs and symptoms
behavioral symptoms
social behavior disorders
mood disorders
attention deficit disorder with hyperactivity
anxiety disorders
family relations
socioeconomic factors
evaluation studies as topic
substance abuse detection
substance abuse detection
risk assessment
alcoholism
alcoholism
alcohol drinking
mass screening
mass screening
pathological conditions, signs and symptoms
Biomarkers
smoking
tobacco use disorder
tobacco use disorder
smoking
guidelines as topic
smoking cessation
marijuana abuse
marijuana abuse
opioid-related disorders
hallucinogens
psychotropic drugs
helping behavior
substance-related disorders
communication
counseling
health education
community networks
education, continuing
health policy
risk assessment
substance-related disorders
risk factors
substance-related disorders
substance-related disorders
substance withdrawal syndrome
severity of illness index
age factors
technical report
health policy guidelines
public health guidelines
government publications
questionnaires

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/024000375.pdf
2002
France
French
technical report
psychotropic drugs
adolescent
substance-related disorders
urban population
socioeconomic factors
injections
substance-related disorders
opioid-related disorders
france
central nervous system stimulants
hallucinogens
substance-related disorders

---
https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=61546
1999
false
France
French
technical report
N-Methyl-3,4-methylenedioxyamphetamine
hallucinogens
N-Methyl-3,4-methylenedioxyamphetamine
N-Methyl-3,4-methylenedioxyamphetamine
amphetamine-related disorders
amphetamine-related disorders
amphetamine-related disorders

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.